Jorge Villacian - Concepedia

Author

Jorge Villacian

Tan Tock Seng Hospital

Also Known As

J S VILLACIAN, J S Villacian, J Villacian, J. S. Villacian, J. Villacian, Jorge S. Villacian, Jorge Villacian

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Tan Tock Seng Hospital Dignitas International National University of Singapore University of Zimbabwe Joint Clinical Research Centre

About

Jorge Villacian is an author at Tan Tock Seng Hospital specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	608
2	Public Health	2	2	37
3	Emergency Medicine	2	2	327
4	Cell Biology	1	1	137
5	Epidemiology	1	1	23

Jorge Villacian

Publications

Citations

H-Index

Page 1

	Year	Citations
Severe Acute Respiratory Syndrome (SARS) in Singapore: Clinical Features of Index Patient and Initial Contacts Li Yang Hsu, Cheng-Chuan Lee, Justin A. Green, Emerging infectious diseases Emerging Infectious DiseasesRespiratory DiseasesRadiologic FeaturesAcute CareClinical Epidemiology	2003	284
The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. David H. Dockrell, Andrew D. Badley, Jorge Villacian, Journal of Clinical Investigation ImmunologyImmune SystemImmunotherapyInflammationHuman Retrovirus	1998	137
Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial Pedro Cahn, Jorge Villacian, Adriano Lazzarin, Clinical Infectious Diseases	2006	81
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial Nicholas I. Paton, Cissy Kityo, Immaculate Nankya, The Lancet HIV	2017	79
Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens Jorge Villacian, Natalia Zahonero, Theresa Pattery, Antimicrobial Agents and Chemotherapy ImmunologyAntiviral DrugDrug ResistanceHuman RetrovirusFull Ral Susceptibility	2012	64
Performance of a Population-Based HIV-1 Tropism Phenotypic Assay and Correlation With V3 Genotypic Prediction Tools in Recent HIV-1 Seroconverters Carmen de Mendoza, Kurt Van Baelen, Eva Poveda, JAIDS Journal of Acquired Immune Deficiency Syndromes	2008	46
In-flight transmission of Severe Acute Respiratory Syndrome (SARS): A Case Report Annelies Wilder‐Smith, Hoe Nam Leong, Jorge Villacian Journal of Travel Medicine Acute Lung InjuryIn-flight TransmissionRespiratory DiseasesAcute CareAcute Respiratory Distress Syndrome	2006	43
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial James Hakim, Cissy Kityo, Anne Hoppé, The Lancet Infectious Diseases	2017	41
A pilot study of the safety and efficacy of thymosin<i>α</i>1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy David Chadwick, Jeffrey Pido-Lopez, António Pires, Clinical & Experimental Immunology	2003	37
Prevalence of and Risk Factors for Nasal Colonization With <i>Staphylococcus aureus</i> Among Human Immunodeficiency Virus-Positive Outpatients in Singapore Jorge Villacian, Timothy Barkham, Arul Earnest, Infection Control and Hospital Epidemiology	2004	36

Page 1